Tepezza Hearing Loss
& Tinnitus Lawsuit.
Patients treated for Thyroid Eye Disease with Tepezza infusions are suffering from permanent hearing loss and ringing in the ears. Horizon Therapeutics failed to warn of these risks. Secure your legal settlement today.
Tepezza Lawsuit Facts
- Primary Harm: Permanent Hearing Loss
- Study Evidence: 65% Event Rate
- Legal Status: Active MDL 3079
Note: This dangerous drug claim targets failures in safety labeling for ototoxicity.
Tepezza Hearing Loss Lawsuit Overview
Tepezza (teprotumumab) was approved as a breakthrough treatment for Thyroid Eye Disease (TED). However, victims allege that manufacturer Horizon Therapeutics downplayed the risk of permanent hearing loss and tinnitus. New medical research indicates that the rate of hearing damage is far higher than the 10% originally reported on safety labels.
Infusions can cause irreversible damage to the hair cells in the inner ear. Whether you completed the full course of 8 infusions or stopped early, the Tepezza lawsuit process seeks to recover damages for hearing aid costs, loss of earning capacity, and emotional distress.
Who Qualifies for a Tepezza Claim?
- Usage History: Received one or more infusions of Tepezza for Thyroid Eye Disease.
- Hearing Issues: Developed tinnitus, partial hearing loss, or total deafness during or after treatment.
- Medical Proof: Confirming hearing damage through an audiogram or ENT specialist evaluation.
Visit our Eligibility Tracker to verify your infusion dates.
Injuries Linked to Tepezza Infusions
Permanent Hearing Loss
Irreversible reduction in hearing sensitivity.
Tinnitus
Chronic ringing, buzzing, or hissing in the ears.
Autophony
Hearing your own voice loudly or Echo-like effects.
Hyperacusis
Extreme sensitivity to everyday environmental sounds.
2026 Legal Insight: The Tepezza MDL 3079 is currently active in the Northern District of Illinois. If your quality of life has diminished due to hearing issues after TED treatment, check our Settlement Tracker for live litigation updates.
Tepezza Lawsuit Settlement Payout Estimates
Compensation for Tepezza hearing loss claims depends on the severity of the damage, the need for permanent hearing aids, and the age of the victim. View the estimated tiers below.
Tier 3 Claims
Temporary hearing loss or moderate tinnitus that resolved after treatment.
Tier 2 Claims
Permanent hearing loss requiring hearing aids or chronic, debilitating tinnitus.
Tier 1 Claims
Total deafness in one or both ears or severe hearing loss in younger victims.
Disclaimer: These figures are estimates based on ototoxicity litigation history. Every case is unique.
Tepezza & Hearing Damage News 2026
Updates on Horizon Therapeutics court filings and new medical safety studies.
Fresh Tepezza litigation news is posted weekly.
Tepezza Case Evaluation
Patients who suffered permanent hearing loss or tinnitus after Tepezza infusions have legal rights. Secure the compensation you deserve today.
Tepezza Hearing Loss Lawsuit FAQs
What proof do I need for a Tepezza claim?
To win a Tepezza hearing loss & tinnitus lawsuit, you need infusion records showing you were treated with teprotumumab, and medical records (preferably an audiogram) confirming hearing damage that started during or after the treatment window.
Has Tepezza been recalled by the FDA?
As of 2026, Tepezza has not been recalled, but the FDA updated safety labels in 2023 to include warnings about permanent hearing loss. The focus of current dangerous drug litigation is the manufacturer's failure to provide this warning when the drug was first launched.
How long does it take to receive a Tepezza settlement?
The Tepezza lawsuit is currently in the discovery phase of the federal MDL. Settlements typically follow bellwether trials which establish settlement values. This process can take 12 to 24 months. Traditional claims like asbestos exposure mesothelioma compensation are well-established, whereas Tepezza litigation is newer and developing quickly.
Can I file if I used Tepezza for only a few doses?
Yes. If you suffered documented hearing damage after even a single infusion, you may be eligible. While many victims completed the 8-infusion course, the ototoxicity can occur at any point during the treatment cycle. Consult a legal expert to evaluate your specific case.
Legal Disclaimer: Masstort Traffic is an informational marketing resource and not a law firm. This content is for educational purposes only. All Tepezza exposure claims and lawsuits are evaluated by independent, licensed attorneys.
Nationwide Service: We support hearing loss victims across all 50 US states, providing access to top-tier legal representation for patients in California, Florida, Illinois, Texas, and New York.
